Selected article for: "cell infection and cleavage site"

Author: Iruegas, Ruben; Dosch, Julian; Sikora, Mateusz; Hummer, Gerhard; Covino, Roberto; Ebersberger, Ingo
Title: The evolutionary making of SARS-CoV-2
  • Cord-id: cf9qykht
  • Document date: 2021_2_5
  • ID: cf9qykht
    Snippet: A mechanistic understanding of how SARS-CoV-2 (sarbecovirus, betacoronavirus) infects human cells is emerging, but the evolutionary trajectory that gave rise to this pathogen is poorly understood. Here we scan SARS-CoV-2 protein sequences in-silico for innovations along the evolutionary lineage starting with the last common ancestor of coronaviruses. SARS-CoV-2 substantially differs from viruses outside sarbecovirus both in its set of encoded proteins and in their domain architectures, indicatin
    Document: A mechanistic understanding of how SARS-CoV-2 (sarbecovirus, betacoronavirus) infects human cells is emerging, but the evolutionary trajectory that gave rise to this pathogen is poorly understood. Here we scan SARS-CoV-2 protein sequences in-silico for innovations along the evolutionary lineage starting with the last common ancestor of coronaviruses. SARS-CoV-2 substantially differs from viruses outside sarbecovirus both in its set of encoded proteins and in their domain architectures, indicating divergent functional demands. Within sarbecoviruses, sub-domain level profiling using predicted linear epitopes reveals how the primary interface between host cell and virus, the spike, was gradually reshaped. The only epitope that is private to SARS-CoV-2 overlaps with the furin cleavage site, a “switch” that modulates spike’s conformational landscape in response to host-cell interaction. This cleavage site has fundamental relevance for both immune evasion and cell infection, and the apparently ongoing evolutionary fine-tuning of its use by SARS-CoV-2 should be monitored.

    Search related documents:
    Co phrase search for related documents
    • accessory gene and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8
    • accessory protein and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • accessory protein and low expression: 1, 2
    • acute respiratory syndrome and adjacent peptide: 1, 2, 3, 4, 5, 6, 7, 8
    • acute respiratory syndrome and long deletion: 1
    • acute respiratory syndrome and low complexity: 1, 2, 3, 4, 5
    • acute respiratory syndrome and low cost rapid approach: 1, 2
    • acute respiratory syndrome and low expression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25